Insider: Jacobs Bruce N. Chief Financial Officer - Kymera Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 232,588 | 0 | 232,588 |
| Value | $19,863,015.20 | $0.00 | $19,863,015.20 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/04/2026 | DDS | 447 | Direct | COM | $86.62 | $38,721.24 | 232,588 |
| 03/04/2026 | DDS | 2,519 | Direct | COM | $85.04 | $214,206.69 | 234,472 |
| 03/04/2026 | DDS | 492 | Direct | COM | $84.00 | $41,326.28 | 236,991 |
| 03/04/2026 | DDS | 1,437 | Direct | COM | $85.78 | $123,266.87 | 233,035 |
| 03/02/2026 | DDS | 2,039 | Direct | COM | $87.75 | $178,924.09 | 243,020 |
| 03/02/2026 | DDS | 4,113 | Direct | COM | $89.66 | $368,760.89 | 237,483 |
| 03/02/2026 | DDS | 1,424 | Direct | COM | $88.50 | $126,024.57 | 241,596 |
| 09/17/2025 | DDS | 79,220 | Direct | COM | $50.00 | $3,961,380.26 | 227,409 |
| 03/03/2025 | DDS | 1,281 | Direct | COM | $31.00 | $39,716.89 | 201,886 |
| 03/03/2025 | DDS | 5,754 | Direct | COM | $30.33 | $174,502.13 | 203,167 |
| 03/04/2024 | DDS | 2,378 | Direct | COM | $41.41 | $98,481.30 | 143,907 |
| 03/04/2024 | DDS | 1,301 | Direct | COM | $42.39 | $55,152.51 | 142,606 |
| 03/04/2024 | DDS | 255 | Direct | COM | $43.26 | $11,030.38 | 142,351 |
| 03/02/2023 | DDS | 1,056 | Direct | COM | $30.88 | $32,606.53 | 104,882 |
| 03/02/2023 | DDS | 314 | Direct | COM | $31.40 | $9,858.75 | 104,568 |
| 01/12/2022 | DDS | 6,427 | Direct | COM | $51.21 | $329,149.16 | 26,087 |
| 01/12/2022 | DDS | 7,151 | Direct | COM | $52.13 | $372,788.07 | 18,936 |
| 01/12/2022 | DDS | 1,422 | Direct | COM | $53.27 | $75,746.81 | 17,514 |
| 12/03/2021 | DDS | 7,713 | Direct | COM | $53.31 | $411,187.74 | 19,801 |
| 12/03/2021 | DDS | 1,987 | Direct | COM | $54.32 | $107,929.27 | 17,814 |
| 12/03/2021 | DDS | 300 | Direct | COM | $55.07 | $16,520.01 | 17,514 |
| 09/03/2021 | DDS | 8,500 | Direct | COM | $60.05 | $510,436.05 | 8,756 |
| 09/03/2021 | DDS | 1,500 | Direct | COM | $60.50 | $90,744.00 | 7,256 |
| 06/03/2021 | DDS | 5,506 | Direct | COM | $46.66 | $256,905.00 | 11,494 |
| 06/03/2021 | DDS | 4,494 | Direct | COM | $47.13 | $211,790.09 | 7,256 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research